Clinical trial
Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia
NCT03254186 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia
- Lead sponsor
- Emory University
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- September 18, 2017
- Completion date
- February 1, 2019
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.